Cargando…
Combined treatment with glucosamine and chondroitin sulfate improves rheumatoid arthritis in rats by regulating the gut microbiota
BACKGROUND: To investigate the ameliorative effects of glucosamine (GS), chondroitin sulphate (CS) and glucosamine plus chondroitin sulphate (GC) on rheumatoid arthritis (RA) in rats, and to explore the mechanism of GS, CS and GC in improving RA based on the gut microbiota. METHODS: RA rat models we...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071728/ https://www.ncbi.nlm.nih.gov/pubmed/37016458 http://dx.doi.org/10.1186/s12986-023-00735-2 |
_version_ | 1785019252881752064 |
---|---|
author | Wang, Xuesong Liu, Dongsong Li, Dan Yan, Jiai Yang, Ju Zhong, Xiaohui Xu, Qin Xu, Yuanze Xia, Yanping Wang, Qinyue Cao, Hong Zhang, Feng |
author_facet | Wang, Xuesong Liu, Dongsong Li, Dan Yan, Jiai Yang, Ju Zhong, Xiaohui Xu, Qin Xu, Yuanze Xia, Yanping Wang, Qinyue Cao, Hong Zhang, Feng |
author_sort | Wang, Xuesong |
collection | PubMed |
description | BACKGROUND: To investigate the ameliorative effects of glucosamine (GS), chondroitin sulphate (CS) and glucosamine plus chondroitin sulphate (GC) on rheumatoid arthritis (RA) in rats, and to explore the mechanism of GS, CS and GC in improving RA based on the gut microbiota. METHODS: RA rat models were effectively developed 14 days after CFA injection, and then garaged with GS, CS and GC. Body weight and paw volume of rats were monitored at multiple time points at the beginning of CFA injection. Until D(36), serum and ankle tissue specimens were used to measure levels of circulating inflammatory factors (TNF-α, IL-1β, MMP-3, NO and PGE(2)) and local inflammatory indicators (TLR-4 and NF-κB). On D(18), D(25), and D(36), intergroup gut microbiota was compared using 16S rRNA gene sequencing and bioinformatics analysis. We also performed the correlation analysis of gut bacteria, joint swelling and inflammatory indicators. RESULTS: GC, rather than GS and CS, could reduce right paw volumes, levels of TLR-4 and NF-κB in synovial tissues. In addition, enriched genera in RA model rats screened out by LEfSe analysis could be inhibited by GC intervention, including potential LPS-producing bacteria (Enterobacter, Bacteroides, Erysipelotrichaceae_unclassified and Erysipelotrichaceae_uncultured) and some other opportunistic pathogens (Esherichia_Shigella, Nosocomiicoccus, NK4A214_group, Odoribacter, Corynebacterium and Candidatus_Saccharimonas.etc.) that positively correlated with pro-inflammatory cytokines, right paw volume, and pathology scores. Furthermore, the gut microbiota dysbiosis was observed to recover before alleviating joint swelling after interventions. CONCLUSIONS: GC could inhibit potential LPS-producing bacteria and the activation of TLR-4/NF-κB pathway in RA rats, thus alleviating RA-induced joint injury. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12986-023-00735-2. |
format | Online Article Text |
id | pubmed-10071728 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-100717282023-04-05 Combined treatment with glucosamine and chondroitin sulfate improves rheumatoid arthritis in rats by regulating the gut microbiota Wang, Xuesong Liu, Dongsong Li, Dan Yan, Jiai Yang, Ju Zhong, Xiaohui Xu, Qin Xu, Yuanze Xia, Yanping Wang, Qinyue Cao, Hong Zhang, Feng Nutr Metab (Lond) Research BACKGROUND: To investigate the ameliorative effects of glucosamine (GS), chondroitin sulphate (CS) and glucosamine plus chondroitin sulphate (GC) on rheumatoid arthritis (RA) in rats, and to explore the mechanism of GS, CS and GC in improving RA based on the gut microbiota. METHODS: RA rat models were effectively developed 14 days after CFA injection, and then garaged with GS, CS and GC. Body weight and paw volume of rats were monitored at multiple time points at the beginning of CFA injection. Until D(36), serum and ankle tissue specimens were used to measure levels of circulating inflammatory factors (TNF-α, IL-1β, MMP-3, NO and PGE(2)) and local inflammatory indicators (TLR-4 and NF-κB). On D(18), D(25), and D(36), intergroup gut microbiota was compared using 16S rRNA gene sequencing and bioinformatics analysis. We also performed the correlation analysis of gut bacteria, joint swelling and inflammatory indicators. RESULTS: GC, rather than GS and CS, could reduce right paw volumes, levels of TLR-4 and NF-κB in synovial tissues. In addition, enriched genera in RA model rats screened out by LEfSe analysis could be inhibited by GC intervention, including potential LPS-producing bacteria (Enterobacter, Bacteroides, Erysipelotrichaceae_unclassified and Erysipelotrichaceae_uncultured) and some other opportunistic pathogens (Esherichia_Shigella, Nosocomiicoccus, NK4A214_group, Odoribacter, Corynebacterium and Candidatus_Saccharimonas.etc.) that positively correlated with pro-inflammatory cytokines, right paw volume, and pathology scores. Furthermore, the gut microbiota dysbiosis was observed to recover before alleviating joint swelling after interventions. CONCLUSIONS: GC could inhibit potential LPS-producing bacteria and the activation of TLR-4/NF-κB pathway in RA rats, thus alleviating RA-induced joint injury. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12986-023-00735-2. BioMed Central 2023-04-04 /pmc/articles/PMC10071728/ /pubmed/37016458 http://dx.doi.org/10.1186/s12986-023-00735-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Wang, Xuesong Liu, Dongsong Li, Dan Yan, Jiai Yang, Ju Zhong, Xiaohui Xu, Qin Xu, Yuanze Xia, Yanping Wang, Qinyue Cao, Hong Zhang, Feng Combined treatment with glucosamine and chondroitin sulfate improves rheumatoid arthritis in rats by regulating the gut microbiota |
title | Combined treatment with glucosamine and chondroitin sulfate improves rheumatoid arthritis in rats by regulating the gut microbiota |
title_full | Combined treatment with glucosamine and chondroitin sulfate improves rheumatoid arthritis in rats by regulating the gut microbiota |
title_fullStr | Combined treatment with glucosamine and chondroitin sulfate improves rheumatoid arthritis in rats by regulating the gut microbiota |
title_full_unstemmed | Combined treatment with glucosamine and chondroitin sulfate improves rheumatoid arthritis in rats by regulating the gut microbiota |
title_short | Combined treatment with glucosamine and chondroitin sulfate improves rheumatoid arthritis in rats by regulating the gut microbiota |
title_sort | combined treatment with glucosamine and chondroitin sulfate improves rheumatoid arthritis in rats by regulating the gut microbiota |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071728/ https://www.ncbi.nlm.nih.gov/pubmed/37016458 http://dx.doi.org/10.1186/s12986-023-00735-2 |
work_keys_str_mv | AT wangxuesong combinedtreatmentwithglucosamineandchondroitinsulfateimprovesrheumatoidarthritisinratsbyregulatingthegutmicrobiota AT liudongsong combinedtreatmentwithglucosamineandchondroitinsulfateimprovesrheumatoidarthritisinratsbyregulatingthegutmicrobiota AT lidan combinedtreatmentwithglucosamineandchondroitinsulfateimprovesrheumatoidarthritisinratsbyregulatingthegutmicrobiota AT yanjiai combinedtreatmentwithglucosamineandchondroitinsulfateimprovesrheumatoidarthritisinratsbyregulatingthegutmicrobiota AT yangju combinedtreatmentwithglucosamineandchondroitinsulfateimprovesrheumatoidarthritisinratsbyregulatingthegutmicrobiota AT zhongxiaohui combinedtreatmentwithglucosamineandchondroitinsulfateimprovesrheumatoidarthritisinratsbyregulatingthegutmicrobiota AT xuqin combinedtreatmentwithglucosamineandchondroitinsulfateimprovesrheumatoidarthritisinratsbyregulatingthegutmicrobiota AT xuyuanze combinedtreatmentwithglucosamineandchondroitinsulfateimprovesrheumatoidarthritisinratsbyregulatingthegutmicrobiota AT xiayanping combinedtreatmentwithglucosamineandchondroitinsulfateimprovesrheumatoidarthritisinratsbyregulatingthegutmicrobiota AT wangqinyue combinedtreatmentwithglucosamineandchondroitinsulfateimprovesrheumatoidarthritisinratsbyregulatingthegutmicrobiota AT caohong combinedtreatmentwithglucosamineandchondroitinsulfateimprovesrheumatoidarthritisinratsbyregulatingthegutmicrobiota AT zhangfeng combinedtreatmentwithglucosamineandchondroitinsulfateimprovesrheumatoidarthritisinratsbyregulatingthegutmicrobiota |